Streamlining Sleep Apnea Diagnoses

Doctors perform sleep studies or polysomnography (PSG) to diagnose sleep related illness or symptoms. Traditionally, patients have a diagnostic study performed for an entire night to diagnose obstructive sleep apnea (OSA bipap machine. Once the doctor confirms OSA, he sets up a separate therapeutic study. During this second study the doctor adjusts (or titrates) continuous or bilevel positive airway pressure (CPAP or BiPAP) to levels that eliminate or significantly reduce the number of respiratory abnormalities (apneas and hypopneas).

Doctors perform therapeutic PSG with CPAP titration if patients have a diagnostic study demonstrating an apnea-hypopnea index (AHI). They may also perform it if the patient’s respiratory disturbance index (RDI) of at least 20 events per hour regardless of symptoms or an AHI/RDI of 10 events per hour associated with excessive daytime somnolence (EDS).

To reduce costs and improve efficiency many centers now combine the diagnostic and therapeutic studies into a single night, called a split-night study. Research by Yamashiro and Kryger, as well as Rodway and Sanders have demonstrated the effectiveness of this strategy especially in patients with significant elevations in AHI/RDI. Split night studies are now incorporated into the guidelines for treatment of OSA published by the American College of Chest Physicians (ACCP).

Split-night polysomnography (PSG) divides the patients testing into two phases in one night. During the first part of the night, sleep specialists diagnose obstructive sleep apnea (OSA) and the second half determine the appropriate level of positive airway pressure (CPAP or BiPAP). Medical necessity guidelines for PSG must meet two conditions for healthcare plan payments. The patient must show a respiratory disturbance index (RDI) greater than 40 during the first two hours of testing; or a RDI of 20-40 if associated with prolonged events or significant desaturations. Split night testing has shown to be less dependable.

There is good evidence that split-night studies can be used under these guidelines. The challenge is that the patient must fall asleep promptly and demonstrate an elevated RDI early in the evening. Only about 25-30 percent of patients have successful split-night studies. The patient must have at least two hours of sleep documented in the diagnostic phase of the study with the documented increase in AHI/RDI. At least three hours of time is necessary for the therapeutic phase.